RAD51抑制剂B02结构式
|
常用名 | RAD51抑制剂B02 | 英文名 | B02 |
|---|---|---|---|---|
| CAS号 | 1290541-46-6 | 分子量 | 339.39000 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C22H17N3O | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS07 |
信号词 | Warning |
RAD51抑制剂B02用途RAD51 Inhibitor B02 (B02)是人RAD51的抑制剂,IC50值为27.4 μM。 |
| 中文名 | RAD51抑制剂B02 |
|---|---|
| 英文名 | (E)-3-benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one |
| 英文别名 | 更多 |
| 描述 | RAD51 Inhibitor B02 (B02)是人RAD51的抑制剂,IC50值为27.4 μM。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
IC50: 27.4 μM (hRAD51)[1] |
| 体外研究 | RAD51抑制剂B02特异性抑制人RAD51(IC50 =27.4μM),但不抑制其大肠杆菌同源物RecA(IC50>250μM)[1]。 B02与顺铂的组合对人乳腺癌细胞MDA-MB-231具有最强的杀伤作用[2]。 |
| 体内研究 | B02显着增强顺铂对体内肿瘤细胞的治疗效果。小鼠以高达50mg/kg的剂量耐受B02而没有明显的体重减轻。在仅用B02处理的小鼠上未观察到肿瘤生长的抑制。然而,用4mg/kg顺铂处理的小鼠显示33%的肿瘤生长抑制。最后,用50mg/kg B02和4mg/kg顺铂治疗的小鼠显示66%的肿瘤生长抑制[2]。 |
| 细胞实验 | 将细胞暴露1小时,然后将细胞用PBS洗涤三次并用含有B02(5μM)的培养基更新。 7-10天后,固定细胞并用染色溶液(0.05%结晶紫,50%甲醇的PBS溶液)染色;最后计算细胞集落[2]。 |
| 动物实验 | 小鼠:在注射前立即将顺铂和B02溶解于NS和cremophor / DMSO / NS(1:1:3)载体中。在联合治疗组中,给小鼠注射B02(50mg / kg或另有说明)和顺铂(4mg / kg或另外表示)。在B02组中,给小鼠注射B02和NS;在顺铂组中,给小鼠注射顺铂和B02载体。在B02(或其载体)注射后3小时施用顺铂(或NS)。所有治疗均在肿瘤细胞接种后第11,13,15和17天通过IP注射进行[2]。 |
| 参考文献 |
| 分子式 | C22H17N3O |
|---|---|
| 分子量 | 339.39000 |
| 精确质量 | 339.13700 |
| PSA | 47.78000 |
| LogP | 4.01020 |
| InChIKey | GEKDQXSPTHHANP-OUKQBFOZSA-N |
| SMILES | O=c1c2ccccc2nc(C=Cc2cccnc2)n1Cc1ccccc1 |
| 外观性状 | 粉末 |
| 储存条件 | -20℃ |
|
A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.
Oncogene 35 , 22-34, (2016) Fanconi anemia (FA) is a genetic disease of bone marrow failure, cancer susceptibility, and sensitivity to DNA crosslinking agents. FANCD2, the central protein of the FA pathway, is monoubiquitinated ... |
|
|
Survival of the replication checkpoint deficient cells requires MUS81-RAD52 function.
PLoS Genet. 9 , e1003910, (2013) In checkpoint-deficient cells, DNA double-strand breaks (DSBs) are produced during replication by the structure-specific endonuclease MUS81. The mechanism underlying MUS81-dependent cleavage, and the ... |
|
实验名称:Primary cell-based high-throughput screening assay for identification of compounds th...
来源:Johns Hopkins Ion Channel Center
靶标:regulator of G-protein signaling 4 isoform 2 [Homo sapiens]
External Id:JHICC_RGS_Act_HTS
|
|
实验名称:Inhibition of human RAD51 in HEK-GFP cells assessed as reduction in double-strand bre...
来源:ChEMBL
靶标:DNA repair protein RAD51 homolog 1
External Id:CHEMBL2039731
|
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
实验名称:Inhibition of RAD51 in MEF cells assessed as potentiation of 32 uM cisplatin-induced ...
来源:ChEMBL
靶标:DNA repair protein RAD51 homolog 1
External Id:CHEMBL2039734
|
|
实验名称:Inhibition of RAD51 in MEF cells assessed as potentiation of 1 uM MMC-induced cytotox...
来源:ChEMBL
靶标:DNA repair protein RAD51 homolog 1
External Id:CHEMBL2039735
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:Inhibition of human RAD51 in HEK-GFP cells assessed as reduction in double-strand bre...
来源:ChEMBL
靶标:DNA repair protein RAD51 homolog 1
External Id:CHEMBL2039732
|
| (E)-3-BENZYL-2-(2-(PYRIDIN-3-YL)VINYL)QUINAZOLIN-4(3H)-ONE |
| 3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone |
| RAD51 inhibitor B02 |
| B02 |